Processa Pharmaceuticals, Inc. Stock
Stocks
PCSA
US74275C4033
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
06:30:00 24/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 1.890 USD | +0.53% |
|
-3.41% | -34.38% |
| Market Cap | 6.33M 5.56M 5.23M 4.78M 8.93M 607M 9M 62.78M 24.34M 309M 23.79M 23.27M 1B | P/E 2024 |
-0.23x | P/E 2025 | -0.28x |
|---|---|---|---|---|---|
| Enterprise Value | 798K 700K 658K 602K 1.12M 76.43M 1.13M 7.91M 3.07M 38.97M 3M 2.93M 126M | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
85.18% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PCSA | Delayed | |
CBOE
| PCSA | Real-time |
Last Transcript: Processa Pharmaceuticals, Inc.
| 1 day | +0.53% | ||
| 1 week | -3.41% | ||
| Current month | -7.80% | ||
| 1 month | -9.13% | ||
| 3 months | -9.13% | ||
| 6 months | -18.53% | ||
| Current year | -34.38% |
| 1 week | 1.84 |  | 2.02 |
| 1 month | 1.82 | | 2.28 |
| Current year | 1.67 | | 3.8 |
| 1 year | 1.67 | | 14.24 |
| 3 years | 1.67 | | 450 |
| 5 years | 1.67 | | 4,495.35 |
| 10 years | 1.67 | | 125,195.11 |
| Manager | Title | Age | Since |
|---|---|---|---|
George Ng
CEO | Chief Executive Officer | 52 | 08/08/2023 |
Patrick Lin
IRC | Investor Relations Contact | 60 | 29/03/2011 |
Wendy Guy
ADM | Chief Administrative Officer | 61 | 04/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
David Young
CHM | Chairman | 73 | 29/03/2011 |
Justin Yorke
CHM | Chairman | 60 | 16/08/2022 |
Geraldine Pannu
BRD | Director/Board Member | 56 | 13/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/8/26 | Exercice | Chief Executive Officer | 3,200 | 0.1156% | ||
| 26/7/26 | Other | Chief Financial Officer | 11,883 | 0.4293% | ||
| 26/7/26 | Other | Chief Executive Officer | 9,384 | 0.3390% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.53% | -3.41% | -61.74% | -98.65% | 6.3M | |
| +0.06% | +7.20% | +54.04% | +111.13% | 74.27B | |
| -2.29% | -2.68% | +32.41% | +75.07% | 61.21B | |
| +0.28% | +7.27% | +31.74% | +23.80% | 27.55B | |
| -2.05% | -1.32% | -18.40% | +352.20% | 26.38B | |
| -2.39% | +1.83% | -0.26% | -5.91% | 25.34B | |
| +0.57% | +6.60% | +26.25% | -9.37% | 20.84B | |
| -1.47% | +4.46% | -8.09% | +513.33% | 14.94B | |
| +1.29% | -2.49% | +163.31% | +333.06% | 15.17B | |
| -2.44% | -0.30% | +43.33% | +164.11% | 14.41B | |
| Average | -0.79% | +2.49% | +26.26% | +145.88% | 28.01B | |
| Weighted average by Cap. | -0.96% | +3.08% | +35.37% | +134.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -11.85M -10.4M -9.78M -8.94M -16.7M -1.14B -16.83M -117M -45.53M -579M -44.5M -43.53M -1.88B | -13.56M -11.9M -11.19M -10.23M -19.12M -1.3B -19.26M -134M -52.11M -662M -50.94M -49.82M -2.15B |
| Net Debt | -1.12M -981K -922K -843K -1.58M -107M -1.59M -11.08M -4.29M -54.59M -4.2M -4.11M -177M | -5.54M -4.86M -4.57M -4.18M -7.8M -530M -7.86M -54.87M -21.27M -270M -20.79M -20.34M -877M |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | USD 1.890 | +0.53% | 4,739 |
| 22/09/26 | USD 1.880 | +2.17% | 74,522 |
| 21/09/26 | USD 1.840 | -6.12% | 16,472 |
| 18/09/26 | USD 1.960 | +3.16% | 6,411 |
| 17/09/26 | USD 1.900 | +2.70% | 21,768 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PCSA Stock
Select your edition
All financial news and data tailored to specific country editions
